Charles Schwab Investment Management Inc Dynavax Technologies Corp Transaction History
Charles Schwab Investment Management Inc
- $601 Billion
- Q3 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 888,533 shares of DVAX stock, worth $9.83 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
888,533
Previous 998,235
10.99%
Holding current value
$9.83 Million
Previous $9.9 Million
10.9%
% of portfolio
0.0%
Previous 0.0%
Shares
34 transactions
Others Institutions Holding DVAX
# of Institutions
304Shares Held
120MCall Options Held
293KPut Options Held
311K-
Black Rock Inc. New York, NY21.9MShares$242 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.7MShares$174 Million4.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$89.6 Million0.0% of portfolio
-
State Street Corp Boston, MA6.29MShares$69.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.53MShares$50.1 Million0.02% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.4B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...